These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 18304457)

  • 1. Are we ready for prostate cancer?
    Na YQ
    Chin Med J (Engl); 2008 Feb; 121(4):291. PubMed ID: 18304457
    [No Abstract]   [Full Text] [Related]  

  • 2. Mass screening-based case-control study of diet and prostate cancer in Changchun, China.
    Li XM; Li J; Tsuji I; Nakaya N; Nishino Y; Zhao XJ
    Asian J Androl; 2008 Jul; 10(4):551-60. PubMed ID: 18478158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer and vasectomy: a hospital-based case-control study in China, Nepal and the Republic of Korea.
    Schwingl PJ; Meirik O; Kapp N; Farley TM;
    Contraception; 2009 May; 79(5):363-8. PubMed ID: 19341848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The detection rate of prostate cancer in different prostate-specific antigen (PSA) levels in Chinese men].
    Li M; Na YQ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):16-8. PubMed ID: 18346372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental prostate cancer in radical cystoprostatectomy specimens.
    Jin XD; Chen ZD; Wang B; Cai SL; Yao XL; Jin BY
    Asian J Androl; 2008 Sep; 10(5):809-14. PubMed ID: 18645685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary cancer and relapse rates following radical prostatectomy for prostate-confined cancer.
    Wesley D; Cox HF
    J Insur Med; 2007; 39(4):242-50. PubMed ID: 18522141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiology of prostate cancer from three centers and analysis of the first-line hormonal therapy for the advanced disease].
    Ma CG; Ye DW; Li CL; Zhou FJ; Yao XD; Zhang SL; Dai B; Zhang HL; Zhu Y; Shen YJ
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):921-5. PubMed ID: 19035151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic tumors to the oral and maxillofacial region: a retrospective study of 19 cases in West China and review of the Chinese and English literature.
    Shen ML; Kang J; Wen YL; Ying WM; Yi J; Hua CG; Tang XF; Wen YM
    J Oral Maxillofac Surg; 2009 Apr; 67(4):718-37. PubMed ID: 19304027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare case of urinary bladder leiomyosarcoma accompanied by prostate cancer.
    Labanaris AP; Zugor V; Meyer B; Scheuering S; Takriti S; Kuhn R
    Can J Urol; 2008 Apr; 15(2):4009-11. PubMed ID: 18405451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens and the molecular epidemiology of prostate cancer.
    Chu LW; Reichardt JK; Hsing AW
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):261-70. PubMed ID: 18438175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
    Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
    J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of prostate cancer susceptibility with genetic polymorphism of cytochrome P450 2E1, smoking and drinking: a case-control study in the population of Nanjing area].
    Yang J; Gu M; Song NH; Feng NH; Hua LX; Ju XB; Sui YG; Wang XR; Wu HF
    Zhonghua Nan Ke Xue; 2009 Jan; 15(1):7-11. PubMed ID: 19288740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current methods of radical treatment for localized prostate cancer].
    Kaprin AD; Khmelevskiĭ EV; Fadeev AV
    Vopr Onkol; 2008; 54(1):108-12. PubMed ID: 18416071
    [No Abstract]   [Full Text] [Related]  

  • 14. Polymorphisms in tumor necrosis factor-A gene and prostate cancer risk in North Indian cohort.
    Kesarwani P; Mandhani A; Mittal RD
    J Urol; 2009 Dec; 182(6):2938-43. PubMed ID: 19846139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer.
    Arsova-Sarafinovska Z; Matevska N; Petrovski D; Banev S; Dzikova S; Georgiev V; Sikole A; Sayal A; Aydin A; Suturkova L; Dimovski AJ
    Cell Biochem Funct; 2008 Oct; 26(7):771-7. PubMed ID: 18646267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy.
    Sørensen KD; Wild PJ; Mortezavi A; Adolf K; Tørring N; Heebøll S; Ulhøi BP; Ottosen P; Sulser T; Hermanns T; Moch H; Borre M; Ørntoft TF; Dyrskjøt L
    Clin Cancer Res; 2009 Feb; 15(4):1400-10. PubMed ID: 19228741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.
    Shaik AP; Jamil K; Das P
    Urol J; 2009; 6(2):78-86. PubMed ID: 19472123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Y chromosome haplotypes and prostate cancer in Sweden.
    Lindström S; Adami HO; Adolfsson J; Wiklund F
    Clin Cancer Res; 2008 Oct; 14(20):6712-6. PubMed ID: 18927315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.
    Johansson M; McKay JD; Wiklund F; Rinaldi S; Hallmans G; Bälter K; Adami HO; Grönberg H; Stattin P; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1644-50. PubMed ID: 19423539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostatic cancer, surgical treatment of localized disease--current and future challenge].
    Jakobsen H
    Ugeskr Laeger; 2008 Aug; 170(34):2543. PubMed ID: 18761835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.